US-FDA Filing

被引：0

作者：

Geetha, L. ^{[1
]}

Swarnakumari, P. ^{[1
]}

机构：

[1] MNR Coll Pharm, Sangareddy 502294, AP, India

来源：

INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2009年 / 71卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：191 / 191

页数：1

共 50 条

[21] ICH and US-FDA validated HPTLC methods with greenness assessments for the assay of mixtures prescribed in stroke prophylaxis: application to pharmaceutical preparations and human plasma
Mohamed M. A. Hamdy
Mohamed A. Korany
Shaza A. Ebied
Rim S. Haggag
JPC – Journal of Planar Chromatography – Modern TLC, 2022, 35 : 519 - 532
[22] Electronic filing for US court documents
不详
INTERNATIONAL JOURNAL OF MICROGRAPHICS & OPTICAL TECHNOLOGY, 2001, 19 (01): : 7 - 7
[23] LIVER INJURY WITH DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITORS (GLIPTINS): SIGNALS EMERGING FROM THE US-FDA ADVERSE EVENT REPORTING SYSTEM
Raschi, E.
Poluzzi, E.
Koci, A.
Antonazzo, I. C.
De Ponti, F.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E106 - E106
[24] Filing of EORTC SOP's at FDA will speed approval of drugs from Europe
Henrar, REC
EUROPEAN JOURNAL OF CANCER, 1996, 32A (03) : 389 - 389
[25] US leads in the filing of patent applications for human DNA
不详
BIOTECHNOLOGY LAW REPORT, 2003, 22 (01) : 18 - 19
[26] US patent filing strategies for small chemical businesses
Burton, Carlyn
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[27] Aubagio approved by US FDA
O'Hare, Alice
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2012, 8 (08) : 703 - 703
[28] US FDA GuidanceApropos of PROs
Paul Kind
PharmacoEconomics, 2006, 24 : 833 - 836
[29] Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (Mpro) by using STD-NMR spectroscopy, in silico studies and antiviral assays
Khan, Abdul Mateen
Atia-tul-Wahab
Farooq, Saba
Ullah, Asmat
Choudhary, M. Iqbal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 234
[30] US FDA alert for Tussionex
Reactions Weekly, 2008, 1193 (1) : 3 - 3

← 1 2 3 4 5 →